Leave Your Message
Nitroxoline 4008-48-4 ≥99% Purity Pharmaceutical Grade - China Suppliers & Factory for Urinary Antibacterial Agent
Hot Products

Nitroxoline 4008-48-4 ≥99% Purity Pharmaceutical Grade - China Suppliers & Factory for Urinary Antibacterial Agent

Nitroxoline (5-nitroquinolin-8-ol) is a highly effective urinary antibacterial agent that targets both gram-positive and gram-negative bacteria commonly associated with urinary tract infections. As a trusted product from China, our Nitroxoline is manufactured in a state-of-the-art factory, ensuring the highest quality standards. We are proud to be one of the leading suppliers in the industry, providing reliable solutions for urinary health. Choose our premium Nitroxoline for effective treatment and support against urinary infections

    Product parameters

    Product Name Nitroxoline
    CAS NO 4008-48-4
    Structure Nitroquinoline Structure
    Molecular formula C9H6N2O3
    Purity Over 99.5%
    Other product names 5-Nitro-8-quinolinol, 8-Hydroxy-5-nitroquinoline, 5-Nitro-8-hydroxyquinoline, 5-nitroquinolin-8-ol
    Molecular weight 190.16

    In vitro activity

    Using spectrophotometric fluorescence assay, Nitroxoline can significantly reduce the degradation of extracellular DQ collagen IV in all tested cancer cell lines. Nitroxoline can significantly reduce real-time monitoring of tumor cell invasion and decrease the invasive growth of multicellular tumor spheroids, which can be used as a three-dimensional vitreous model of tumor invasion. In vitro angiogenesis experiments, Nitroxoline can significantly reduce the formation of endothelial tubes.

    In vitro activity

    Nitroxoline significantly inhibited tumor growth,angiogenesis and metastasis in LPB fibrosarcoma and MMTV PyMT breast cancer mouse models.

    Kinase experiment

    In Vitro Kinase Assays : The potency of SP600125 towards kinases, including MPS1, JNK, and Aurora kinase A, is determined based on the specific measurement of radioactive phosphotransfer to the substrate. For each enzyme, the absolute Km values for ATP and the specific substrate are initially determined and each assay is then run at optimized [ATP] (2·αKm) and [substrate] (5·Km) concentrations. MPS1 activity is measured using 5 nM of MPS1 recombinant protein in 50 mM HEPES pH 7.5, 2.5 mM MgCl2, 1 mM MnCl2, 1 mM DTT, 3 μM NaVO3, 2 mM β-glycerophosphate, 0.2 mg/mL BSA, 200 μM P38-βtide substrate-peptide (KRQADEEMTGYVATRWYRAE), and 8 μM ATP with 1.5 nM 33P-γ-ATP. Ten serial 1:3 dilutions (from 30 μM to 1.5 nM) of SP600125 are tested and IC50 determined.
    Kinase Assay Analysis
    Laboratory Experimentation

    Cell experiment

    Cell suspension are seeded in the wells of an E-plate 16 according to the manufacturer's instructions. After seeding, the CI is monitored every 15 min. After ∼10 h (MCF-10A neoT and MMTV-PyMT), 14 h (U-87 MG) or 24 h (LPB), when the cells are in their log phase of growth, 50 μl of the compound or 0.1% DMSO is added, and the experiment allowed to run for 72 h. Once every 24 h the medium is replaced with fresh medium containing the inhibitor or suitable control to prevent cell death due to medium depletion. Compounds and their concentrations are: nitroxoline (5 μM) and CA-074 (5 μM) for all cell lines other than MCF-10A neoT cell line, where nitroxoline was used at 2.5 μM. All measurements were performed in quadruplicate. (Only for Reference)

    Frequently Asked Questions

    What is the CAS registry number and molecular formula of Nitroxoline?

    Nitroxoline has the CAS number 4008-48-4 and the molecular formula C9H6N2O3.

    What are the alternative chemical names for Nitroxoline?

    Nitroxoline is also known as 5-Nitro-8-quinolinol, 8-Hydroxy-5-nitroquinoline, 5-Nitro-8-hydroxyquinoline, and 5-nitroquinolin-8-ol.

    How does Nitroxoline perform in terms of purity?

    The product features high-grade purity of over 99.5% with a molecular weight of 190.16.

    What are the primary in vitro biological activities of Nitroxoline?

    In vitro assays demonstrate that Nitroxoline significantly reduces the degradation of extracellular DQ collagen IV in cancer cell lines, decreases real-time tumor cell invasion, curtails multicellular tumor spheroid growth, and limits endothelial tube formation during angiogenesis.

    What has mouse model testing shown regarding Nitroxoline's efficacy?

    In vivo tests using LPB fibrosarcoma and MMTV PyMT breast cancer mouse models show that Nitroxoline significantly inhibits tumor growth, angiogenesis, and metastasis.

    What concentrations of Nitroxoline are recommended for cell experiments?

    For cell culture experiments, a concentration of 5 μM of Nitroxoline is typically utilized for most tested cell lines, whereas a lower concentration of 2.5 μM is applied specifically for the MCF-10A neoT cell line.